Translational Oncology

杂志介绍

Translational Oncology杂志介绍

《Translational Oncology》是一本以English为主的开放获取国际优秀期刊，中文名称转化肿瘤学，本刊主要出版、报道医学-ONCOLOGY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为4.5，最新CiteScore 指数为8.4。

本刊近期中国学者发表的论文主要有：

• Loss of BLK expression as a potential predictor of poor prognosis and immune checkpoint blockade response in NSCLC and contribute to tumor progression

  Author: Xu, Yingqi; Xu, Jianlin; Qiao, Rong; Zhong, Hua; Xia, Jinjing; Zhong, Runbo

• The roles of Linc-ROR in the regulation of cancer stem cells

  Author: Wen, Xiaoling; Wu, Yingying; Lou, Yanhui; Xia, Yufang; Yu, Xiao

• Immune microenvironment and therapeutic progress of recurrent hepatocellular carcinoma after liver transplantation

  Author: Jin, Xin; Ma, Xiaoting; Zhao, Dong; Yang, Lin; Ma, Nan

• circ-ZEB1 regulates epithelial-mesenchymal transition and chemotherapy resistance of colorectal cancer through acting on miR-200c-5p

  Author: Chen, Hongyu; Zhang, Jianwei; Yang, Lei; Li, Yansen; Wang, Zhenjun; Ye, Chunxiang

英文介绍

Translational Oncology杂志英文介绍

Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Peer reviewed manuscript types include Original Reports, Reviews and Editorials.